In another study conducted by Sakurai et al., the administration of M-CSF was found to control antigen-specific immune responses due to increases in B cells, natural killer cells, and the activation of murine macrophages for tumor killing (Sakurai et al., 2008). Here, CSF1 is linked to neoplasm.